Implantable MEMS drug delivery device for cancer radiation reduction

We present the first implantable MEMS drug delivery device that includes an electrochemical bellows pump, refillable drug reservoir, and dual regulation valve. Multiple drug pump configurations were fabricated, assembled, and tested. Delivery of agents for cancer radiation reduction was demonstrated. In vivo chronic delivery of radiation sensitizing agents in the form of small interfering (siRNA)-gold nanorod complexes (nanoplexes) directly to tumors induced in mice was achieved. Radiation therapy in conjunction with active drug pumping by electrolysis actuation resulted in significant reduction of colon cancer tumor (HT29) size (∼50%) over diffusion-based delivery and intravenous injections. To our knowledge, this is the first MEMS drug delivery pump suitable for safe, efficacious, and local delivery of short half-life siRNA in vivo.

[1]  E. Meng,et al.  In-Plane Bandpass Regulation Check Valve in Heat-Shrink Packaging for Drug Delivery , 2009, 2009 IEEE 22nd International Conference on Micro Electro Mechanical Systems.

[2]  E. Meng,et al.  A parylene bellows electrochemical actuator for intraocular drug delivery , 2009, TRANSDUCERS 2009 - 2009 International Solid-State Sensors, Actuators and Microsystems Conference.

[3]  J. Lieberman,et al.  The silent treatment: siRNAs as small molecule drugs , 2006, Gene Therapy.

[4]  E. Meng,et al.  A Parylene Bellows Electrochemical Actuator , 2010, Journal of Microelectromechanical Systems.

[5]  O. Cuvillier,et al.  Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1 , 2006, Leukemia.